SCHEMBL3176019

SCHEMBL3176019

COc1cccc(CC(=O)NCCNc2cc(NCCNC(C)=O)nc(-c3ccccc3)n2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.57
CYP3A4 P08684 2/20 0.57
CYP2D6 P10635 2/20 0.57
CYP2C19 P33261 2/20 0.57
CLK4 Q9HAZ1 2/20 0.57
TSHR P16473 1/20 0.57
MTNR1A P48039 8/20 0.50
MTNR1B P49286 8/20 0.50
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
ADORA1 P30542 1/20 0.46
ROCK1 Q13464 2/20 0.46
PRKACA P17612 1/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3171330 0.92 CA1 (0.48) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3166238 0.90 ALDH1A1 (0.54) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3156387 0.89 ADORA2A (0.48) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3165164 0.89 CYP1A2 (0.63) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3163133 0.87 TP53 (0.49) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3171164 0.85 MTNR1A (0.49) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3163050 0.85 BCHE (0.45) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3155983 0.85 MTNR1B (0.51) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3162245 0.84 ALDH1A1 (0.47) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3171179 0.83 KMT2A (0.50) CYP1A2CYP3A4CYP2D6CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed